Year of birth: 1959

Wikipedia

BIOGRAPHY

Professor Engert studied and obtained his doctorate in human medicine at the Hannover Medical School and began his clinical training at the Department of Internal Medicine at the University Hospital of Cologne. From 1988 to 1990, he worked at the Imperial Cancer Research Fund in London as part of a DFG (German Research Foundation) fellowship, focusing on the development of new immunotherapeutic approaches for lymphatic neoplasms. In the autumn of 1990, he returned to Cologne, where he established a clinical-scientific Phase I/II program to evaluate antibody-based immunotherapies. In 1995, he completed his habilitation (postdoctoral qualification) and was appointed Senior Physician in the same year. From 1997 to 2000, he headed the Hematology Laboratory at the clinic and led the study secretariat of the department until 2004. From 1996 to 2000, he served as Staff Senior Physician and has been Deputy Director of the Clinic since 2000. In 2001, he was appointed University Professor at the Medical Faculty of Cologne in a C3 professorship.

From 2007 until 2022, Professor Engert has been the Chairman of the German Hodgkin Study Group (GHSG). The GHSG is a network of more than 400 clinics and tumor centers across five European countries.

Professor Engert is a member of numerous national and international scientific associations and led the Cochrane Hematological Malignancies Group (CHMG) as Coordinating Editor from 2000 to 2014.

For his contributions to medical science, he has received numerous awards, including the AIO Science Award (2011) and the Paul Martini Prize (2013). In May 2012, the University of Belgrade awarded him an honorary doctorate.